Focus-X Therapeutics is Drug Discovery in United States that focus on developer business. Founded in 2020. They cover business area such as developer, preclinical stage radiopharmaceutical, cancer, radioligand therapy, alpha or beta emitter, optimization, translation, radioligand theranostic agent, medical practitioner, novel mechanism.
2020
( 4 years old in 2024 )
Developer
-
3541 223rd Avenue SE
Sammamish, WA 98075
United States
Private
developerpreclinical stage radiopharmaceuticalcancerradioligand therapyalpha or beta emitteroptimizationtranslationradioligand theranostic agentmedical practitionernovel mechanism
* We use standard office opening hours in near Focus-X Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Focus-X Therapeutics is Drug Discovery business from United States that founded in 2020 (4 years old in 2024), Focus-X Therapeutics business is focusing on Developer.
Focus-X Therapeutics headquarter office and corporate office address is located in 3541 223rd Avenue SE Sammamish, WA 98075 United States.
Focus-X Therapeutics was founded in United States.
In 2024, Focus-X Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Focus-X Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
